Company profile for Filament Health

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Filament Health is a clinical-stage natural psychedelic drug development company. We are building a comprehensive platform to support the treatment of mental health conditions through the administration of natural psychedelic drug candidates into FDA authorized human clinical trials. These drug candidates have been grown and manufactured by our wholly-owned subsidiary, Psilo Scientific.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
2900 – 550 Burrard Street Vancouver, BC V6C 0A3
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-reports-first-quarter-2025-financials-1028085

ACCESSWIRE
15 May 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/magdalena-biosciences-a-joint-venture-between-jaguar-health-and-filame-980424

ACCESSWIRE
06 Feb 2025

https://www.accesswire.com/964484/magdalena-biosciences-a-joint-venture-between-jaguar-health-and-filament-health-to-present-january-12-at-the-annual-neuroscience-innovation-forum

ACCESSWIRE
07 Jan 2025

https://www.accesswire.com/924759/magdalena-biosciences-a-joint-venture-between-jaguar-health-and-filament-health-to-present-october-16-at-bio-investor-forum

ACCESSWIRE
10 Oct 2024

https://www.globenewswire.com//news-release/2023/11/15/2781064/0/en/PharmAla-Biotech-and-Filament-Health-Announce-Release-of-Second-Batch-of-GMP-MDMA-Capsules.html

GLOBENEWSWIRE
15 Nov 2023

https://www.newswire.ca/news-releases/filament-health-announces-fda-approval-of-phase-ii-clinical-trial-studying-psilocybin-for-methamphetamine-use-disorder-801405766.html

NEWSWIRE
16 Mar 2023

ABOUT THIS PAGE

Contact Filament Health and get a quotation

Filament Health is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Psilocin bulk with DMF offered by Filament Health

Find a price of Psilocybine bulk with DMF offered by Filament Health

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty